Suretox Laboratory
Biogenica Laboratories has been a trusted provider of molecular and toxicology testing services since 2012, delivering accurate and reliable results to clients in the tristate area. Certified by CLIA in New Jersey and CLEP in New York, the company maintains high standards of accuracy and reliability through participation in proficiency testing programs. Their dedicated team provides accurate and timely results for physicians and patients, offering a wide range of testing services including molecular, toxicology, COVID-19, hereditary cancer, pharmacogenetics, and more.
Industries
Nr. of Employees
small (1-50)
Suretox Laboratory
Products
Pharmacogenetics (PGx) gene panel
Multi-gene panel analyzing numerous pharmacogenes to guide medication selection and dosing.
Hereditary cancer gene panel (CGx)
Targeted panel for hereditary cancer-associated genes used in risk assessment.
Neurodegenerative disease gene panel (PAD)
Panel testing for variants associated with Parkinson’s, Alzheimer’s, and related dementias.
Urinary tract infection (UTI) molecular panel
Real-time PCR panel for identification of urinary pathogens and resistance markers with reported high sensitivity and specificity.
Wound infection molecular panel
DNA/RNA-based panel to identify wound pathogens and resistance markers with rapid turnaround.
Respiratory pathogen panel (RPP)
Multiplex assay to detect viral and bacterial respiratory pathogens and provide sub-typing and resistance information where applicable.
Pharmacogenetics (PGx) gene panel
Multi-gene panel analyzing numerous pharmacogenes to guide medication selection and dosing.
Hereditary cancer gene panel (CGx)
Targeted panel for hereditary cancer-associated genes used in risk assessment.
Neurodegenerative disease gene panel (PAD)
Panel testing for variants associated with Parkinson’s, Alzheimer’s, and related dementias.
Urinary tract infection (UTI) molecular panel
Real-time PCR panel for identification of urinary pathogens and resistance markers with reported high sensitivity and specificity.
Wound infection molecular panel
DNA/RNA-based panel to identify wound pathogens and resistance markers with rapid turnaround.
Respiratory pathogen panel (RPP)
Multiplex assay to detect viral and bacterial respiratory pathogens and provide sub-typing and resistance information where applicable.
Services
Molecular diagnostic testing (infectious disease panels)
Laboratory testing for respiratory, urinary, and wound pathogens using multiplex and real-time PCR assays with rapid reporting options.
Pharmacogenetic panel testing (PGx)
Genetic testing to evaluate drug-gene interactions and support medication selection for pain, psychiatric, and cardiovascular therapies.
Hereditary cancer genetic testing (CGx)
Panel testing for inherited variants associated with increased cancer risk to inform risk assessment and prevention recommendations.
Neurodegenerative disease genetic testing (PAD)
Targeted gene panel testing for variants linked to Parkinson’s, Alzheimer’s, and related dementias to inform clinical management and family screening.
Clinical toxicology testing (screening and confirmation)
Urine and oral fluid drug screening and confirmation services, including LC–MS/MS confirmation for a broad range of drug classes.
COVID-19 PCR screening
Real-time PCR screening for SARS‑CoV‑2 from nasal and saliva specimens with rapid turnaround options and support for facility/employer testing programs.
Molecular diagnostic testing (infectious disease panels)
Laboratory testing for respiratory, urinary, and wound pathogens using multiplex and real-time PCR assays with rapid reporting options.
Pharmacogenetic panel testing (PGx)
Genetic testing to evaluate drug-gene interactions and support medication selection for pain, psychiatric, and cardiovascular therapies.
Hereditary cancer genetic testing (CGx)
Panel testing for inherited variants associated with increased cancer risk to inform risk assessment and prevention recommendations.
Neurodegenerative disease genetic testing (PAD)
Targeted gene panel testing for variants linked to Parkinson’s, Alzheimer’s, and related dementias to inform clinical management and family screening.
Clinical toxicology testing (screening and confirmation)
Urine and oral fluid drug screening and confirmation services, including LC–MS/MS confirmation for a broad range of drug classes.
COVID-19 PCR screening
Real-time PCR screening for SARS‑CoV‑2 from nasal and saliva specimens with rapid turnaround options and support for facility/employer testing programs.
Expertise Areas
- Molecular diagnostics
- Infectious disease testing (respiratory, urinary, wound)
- Clinical toxicology and LC–MS/MS confirmation
- Pharmacogenetics (PGx) testing and interpretation
Key Technologies
- Real-time PCR / nucleic acid amplification tests (NAAT)
- Liquid chromatography–tandem mass spectrometry (LC–MS/MS)
- Targeted multi-gene panel testing
- Multiplex respiratory pathogen panels